---
id: "entity-anaeze-c-offodile-ii"
type: "entity"
entityType: "person"
canonicalName: "Anaeze C. Offodile II"
aliases: ["Anaeze Offodile", "Anaeze C. Offodile"]
role: "Co-author of the source article; physician-executive / health-policy voice"
source_timestamps: ["Author byline"]
tags: ["author", "physician-executive"]
related: ["entity-msk", "concept-amc-innovators-dilemma"]
sources: ["tail2"]
isSpeakerEntity: true
---
## Segment 2 — tail2

## Article 131 — a131

# Anaeze C. Offodile II

**Role:** Lead / co-author of the HBR source article "U.S. Medical Centers Need a New Model for Drug Discovery and Development." A physician-executive writing at the intersection of oncology, health strategy, and policy; per public sources he is affiliated with [[entity-msk]] in a strategy leadership capacity.

**Attributed contributions (collective authorship):** as a co-author he advances the article's central thesis — the [[concept-amc-innovators-dilemma]] — and the corrective [[framework-amc-innovation-acceleration]]. The article's quotes are attributed to the authors as a group: [[quote-beijing-boston]], [[quote-innovators-dilemma]], [[quote-disease-borders]].